Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023
08 May 2023 - 10:00PM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced it will report first quarter 2023
financial results after the market close on Thursday, May 11,
2023. Following the release, the Company will host a live
conference call and webcast at 4:30 p.m. ET to discuss
the Company’s financial results and provide a business update.
Event |
Agile Therapeutics First Quarter 2023 Financial Results Conference
Call |
Date |
Thursday, May 11, 2023 |
Time |
4:30 p.m. ET / 1:30 p.m.
PT |
|
|
A live webcast of the conference call may be
accessed via the Investor Relations portion of the Agile
Therapeutics website
at https://ir.agiletherapeutics.com/events-and-presentations.
To participate in the live conference call via telephone, please
register here. Upon registering, a dial-in number and unique
PIN will be provided to join the conference call.
About Agile
Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company
dedicated to fulfilling the unmet health needs of today’s women.
Our product and product candidates are designed to provide women
with contraceptive options that offer freedom from taking a daily
pill, without committing to a longer-acting method. Our initial
product, Twirla®, (levonorgestrel and ethinyl estradiol)
transdermal system, is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The Company
may occasionally disseminate material, nonpublic information on the
Company’s website, Twitter account (@agilether), and LinkedIn
account.
Contact:Matt RileyHead of Investor
Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024